Tomic D, Shaw JE, Magliano DJ (2022) The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol 18:525–539. https://doi.org/10.1038/s41574-022-00690-7
Article PubMed PubMed Central Google Scholar
Abu-Ashour W, Twells L, Valcour J et al (2017) The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies. BMJ Open Diabetes Res Care 5(1):e000336. https://doi.org/10.1136/bmjdrc-2016-000336
Article PubMed PubMed Central Google Scholar
Rao KondapallySeshasai S, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364(9):829–841. https://doi.org/10.1056/NEJMoa1008862
Carey IM, Critchley JA, DeWilde S, Harris T, Hosking FJ, Cook DG (2018) Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care 41(3):513–521. https://doi.org/10.2337/dc17-2131
Harding JL, Benoit SR, Gregg EW, Pavkov ME, Perreault L (2019) Trends in rates of infections requiring hospitalization among adults with versus without diabetes in the U.S., 2000–2015. Diabetes Care 43(1):106–116. https://doi.org/10.2337/dc19-0653
Hartmann-Boyce J, Rees K, Onakpoya I et al (2023) An update to the overview of reviews: risks of and from SARS-COV-2 infection and COVID-19 in people with diabetes. Diabetes Care 46(12):e215–e216. https://doi.org/10.2337/dc23-1365
Mor A, Berencsi K, Nielsen JS et al (2016) Rates of community-based antibiotic prescriptions and hospital-treated infections in individuals with and without type 2 diabetes: a Danish nationwide cohort study, 2004–2012. Clin Infect Dis 63(4):501–511. https://doi.org/10.1093/cid/ciw345
Magliano DJ, Harding JL, Cohen K, Huxley RR, Davis WA, Shaw JE (2015) Excess risk of dying from infectious causes in those with type 1 and type 2 diabetes. Diabetes Care 38(7):1274–1280. https://doi.org/10.2337/dc14-2820
Mor A, Dekkers OM, Nielsen JS, Beck-Nielsen H, Sørensen HT, Thomsen RW (2017) Impact of glycemic control on risk of infections in patients with type 2 diabetes: a population-based cohort study. Am J Epidemiol 186(2):227–236. https://doi.org/10.1093/aje/kwx049
Vasbinder A, Anderson E, Shadid H et al (2022) Inflammation, hyperglycemia, and adverse outcomes in individuals with diabetes mellitus hospitalized for COVID-19. Diabetes Care 45(3):692–700. https://doi.org/10.2337/dc21-2102
Article CAS PubMed PubMed Central Google Scholar
Schlesinger S, Lang A, Christodoulou N et al (2023) Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis. Diabetologia 66(8):1395–1412. https://doi.org/10.1007/s00125-023-05928-1
Article CAS PubMed PubMed Central Google Scholar
Lim S, Bae JH, Kwon HS, Nauck MA (2021) COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 17(1):11–30. https://doi.org/10.1038/s41574-020-00435-4
Article CAS PubMed Google Scholar
Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG (2018) Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care 41(10):2127–2135. https://doi.org/10.2337/dc18-0287
Article CAS PubMed Google Scholar
Harpsøe MC, Nielsen NM, Friis-Møller N et al (2016) Body mass index and risk of infections among women in the Danish national birth cohort. Am J Epidemiol 183(11):1008–1017. https://doi.org/10.1093/aje/kwv300
Kaspersen KA, Pedersen OB, Petersen MS et al (2015) Obesity and risk of infection: results from the Danish Blood Donor Study. Epidemiology 26(4):580–589. https://doi.org/10.1097/ede.0000000000000301
Yang Y, Ding L, Zou X et al (2020) Visceral adiposity and high intramuscular fat deposition independently predict critical illness in patients with SARS-CoV-2. Obesity (Silver Spring) 28(11):2040–2048. https://doi.org/10.1002/oby.22971
Article CAS PubMed Google Scholar
Stidsen JV, Henriksen JE, Olsen MH et al (2018) Pathophysiology-based phenotyping in type 2 diabetes: a clinical classification tool. Diabetes Metab Res Rev 34(5):e3005. https://doi.org/10.1002/dmrr.3005
Article CAS PubMed Google Scholar
Ahlqvist E, Storm P, Käräjämäki A et al (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6(5):361–369. https://doi.org/10.1016/s2213-8587(18)30051-2
Stidsen JV, Christensen DH, Henriksen JE et al (2022) Risk of cardiovascular events associated with pathophysiological phenotypes of type 2 diabetes. Eur J Endocrinol 187(2):279–291. https://doi.org/10.1530/eje-22-0020
Article CAS PubMed Google Scholar
Andersen CJ, Murphy KE, Fernandez ML (2016) Impact of obesity and metabolic syndrome on immunity. Adv Nutr 7(1):66–75. https://doi.org/10.3945/an.115.010207
Article CAS PubMed PubMed Central Google Scholar
Bandaru P, Rajkumar H, Nappanveettil G (2013) The impact of obesity on immune response to infection and vaccine: an insight into plausible mechanisms. Endocrinol Metab Synd 2(2):1000113–1000122
Muscogiuri G, Pugliese G, Laudisio D et al (2021) The impact of obesity on immune response to infection: plausible mechanisms and outcomes. Obes Rev 22(6):e13216. https://doi.org/10.1111/obr.13216
Holman N, Knighton P, Kar P et al (2020) Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol 8(10):823–833. https://doi.org/10.1016/s2213-8587(20)30271-0
Article CAS PubMed PubMed Central Google Scholar
Kornum JB, Nørgaard M, Dethlefsen C et al (2010) Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J 36(6):1330–1336. https://doi.org/10.1183/09031936.00184209
Article CAS PubMed Google Scholar
Chaudhry UAR, Carey IM, Critchley JA et al (2024) A matched cohort study evaluating the risks of infections in people with type 1 diabetes and their associations with glycated haemoglobin. Diabetes Res Clin Pract 207:111023. https://doi.org/10.1016/j.diabres.2023.111023
Article CAS PubMed Google Scholar
Kristensen FPB, Nicolaisen SK, Nielsen JS et al (2024) The Danish centre for strategic research in type 2 diabetes (DD2) project cohort and biobank from 2010 through 2023-a cohort profile update. Clin Epidemiol 16:641–656. https://doi.org/10.2147/clep.S469958
Article PubMed PubMed Central Google Scholar
Laugesen K, Ludvigsson JF, Schmidt M et al (2021) Nordic health registry-based research: a review of health care systems and key registries. Clin Epidemiol 13:533–554. https://doi.org/10.2147/clep.S314959
Article PubMed PubMed Central Google Scholar
Christensen DH, Knudsen ST, Gylfadottir SS et al (2020) Metabolic factors, lifestyle habits, and possible polyneuropathy in early type 2 diabetes: a nationwide study of 5,249 patients in the Danish centre for strategic research in type 2 diabetes (DD2) cohort. Diabetes Care 43(6):1266–1275. https://doi.org/10.2337/dc19-2277
Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27(6):1487–1495. https://doi.org/10.2337/diacare.27.6.1487
Gedebjerg A, Thomsen RW, Kjaergaard AD et al (2021) Mannose-binding lectin and risk of infections in type 2 diabetes: a Danish cohort study. J Diabetes Complications 35(5):107873. https://doi.org/10.1016/j.jdia
留言 (0)